JPRN-UMIN000032341已完成未知
Prospective analysis of cardiovascular events based on titin concentration in patients with chronic heart failure - Analysis of titin in patients with chronic heart failure
Kobe University Graduate School of Medicine Department of Internal Medicine Division of Cardiovascular Medicine0 个研究点目标入组 70 人开始时间: 2018年5月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 70
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 90years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1) Patients with muscular diseases (e.g. muscular dystrophy (2) Situation of muscular destruction (e.g. strenuous training, muscle infection and so on) (3) Patients whose life expectancy is less than 24 months (4) Other cases who are judged to be inappropriate to be included in this study by the chief investigator.
研究者
相似试验
招募中
不适用
A retrospective study of cardiac event occurrence in thoracic carbon-ion radiotherapyung cancer, liver cancer, esophageal cancer etc.JPRN-UMIN000046354ational Institute for Quantum and Radiological Science and Technology200
招募中
不适用
The investigation of optimal cardiovascular treatment with directional coronary atherectomyCoronary atherosclerosis Angina pectoris, Acute coronary syndromeJPRN-UMIN000041784Hyogo Brain and Heart Center200
进行中（未招募）
不适用
Estudio de eventos cardiovasculares para evaluar el potencial de aleglitazar en la reducción del riesgo cardiovascular en pacientes con un episodio reciente de síndrome coronario agudo (SCA) y diabetes mellitus tipo 2 (DM2).Cardiovascular outcomes study to evaluate the potential of aleglitazar to reduce cardiovascular risk in patients with a recent acute coronary syndrome (ACS) event and type 2 diabetes mellitus (T2D).Pacientes con diabetes tipo 2 con un episodio reciente de síndrome coronario agudo (SCA).Type 2 diabetes patients with a recent acute coronary syndrome (ACS) event.MedDRA version: 12.0Level: LLTClassification code 10007649Term: Cardiovascular disorderEUCTR2009-012269-71-ESF. Hoffmann-La Roche Ltd.6,000
已完成
不适用
A prospective surveillance of cardiovascular events in antiplatelet-treated arteriosclerosis obliterans patients in Japan.Arteriosclerosis obliterans Peripheral arterial diseaseJPRN-UMIN000003385Mitsubishi Tanabe Pharma Corporation11,375
招募中
不适用
Investigating cardiovascular adverse events related to cancer treatment: a study of extreme toxicity using induced pluripotent stem cellscardiovascular adverse events after cancer treatment1008220610027655NL-OMON44465niversitair Medisch Centrum Groningen48